Form 4: Orchestra BioMed Holdings Officer Sells Shares to Cover Tax Obligations

Darren Sherman, President and COO of Orchestra BioMed Holdings, sold shares of common stock between September 4th and September 6th, 2024, to cover tax obligations associated with the vesting of restricted stock units.

Summary

• Darren Sherman, President and COO of Orchestra BioMed Holdings, sold shares of common stock between September 4th and September 6th, 2024.
• The sales were executed to cover tax obligations related to the vesting of restricted stock units (RSUs) granted on July 20, 2023.
• On September 4, 2024, 6,837 shares were sold at a weighted average price of $6.10.
• On September 5, 2024, 6,961 shares were sold at a weighted average price of $5.85.
• On September 6, 2024, 6,819 shares were sold at a weighted average price of $5.65.
• Following these transactions, Sherman directly owns 779,495 shares of Orchestra BioMed Holdings.

Sentiment

Score: 5

Explanation: The document itself is neutral, reporting a routine transaction. The sentiment is neutral as the sale is for tax purposes and doesn't necessarily indicate a lack of confidence in the company.

Risks

• Executive share sales could be perceived negatively by investors, potentially impacting the stock price, although these sales are stated to be for tax obligations.

Industry Context

Executive share sales are a common occurrence, particularly to cover tax obligations related to equity compensation. The impact on the stock price often depends on the size of the sale relative to the executive's holdings and the overall market sentiment.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units (RSUs) that vest over time.
• Upon vesting, these RSUs are subject to income tax, and executives frequently sell a portion of the shares to cover these tax liabilities.
• Companies like Medtronic, Boston Scientific, and Abbott also have executives who periodically sell shares for similar reasons.
• The percentage of shares sold for tax purposes typically varies depending on the individual's tax bracket and the company's stock performance.

Stakeholder Impact

• Shareholders may react to the news of executive share sales, although the stated reason (tax obligations) may mitigate negative sentiment.
• The company is not directly impacted, as these are personal transactions of the executive.

Key Dates